From Blindness to “4K” vision: CorNeat Vision’s artificial cornea provides new hope for the corneally blind
Patient Stories: How MedTech Innovator alumni are transforming lives At MedTech Innovator, we empower healthtech companies to bring groundbreaking solutions to patients in need. Our Patient Stories series highlights the real-world clinical impact of the companies we support—showcasing how their... Read More →
Inflammatix Ships TriVerity™ Test Cartridges and Myrna™ Instruments to the U.S. Military
The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) purchases TriVerity Test System to evaluate for use in the field Inflammatix receives an initial $1.2 million to cover the first phase of system evaluation, with future... Read More →
Morningside Ventures Makes Strategic Investment in Xealth to Accelerate Digital Health Ecosystem
BOSTON and SEATTLE–March 25, 2025–Xealth, the leader in digital health enablement for health systems, today announced a strategic investment from Morningside Ventures, a leading investor in healthcare innovation. This investment will strengthen Morningside’s digital health portfolio and expand Xealth’s footprint... Read More →
Cyted Health Expands US Presence with First Patients Enrolled in DETECT-ME Clinical Validation Study
WILMINGTON, Del. and CAMBRIDGE, England, March 25, 2025 /PRNewswire/ — Cyted Health, a leading gastrointestinal molecular diagnostics company, today announces the enrollment of the first patient in the DETECT-ME clinical validation study (NCT06803927). The study evaluates Cyted Health’s advanced molecular assays using esophageal cells... Read More →
Nanowear Announces Continuous Glucose Monitoring (CGM) Licensing and Data Partnership With Dexcom
For Investigational Purposes, Nanowear’s app, platform, and server will transmit Dexcom G7 CGM data, offering first-in-the-world, home-based, self-administered, continuous cardiometabolic assessments NEW YORK–(BUSINESS WIRE)–Nanowear, a leader in home-based cardiometabolic digital diagnostics announced that SimpleSense™, a nanotechnology-enabled wearable, mobile and software... Read More →
Fujifilm strikes partnership with Us2.ai for AI echocardiography analysis
Us2.ai’s AI-based software is being integrated into Fujifilm’s LISENDO ultrasound systems to expedite cardiology image analysis. Fujifilm is collaborating with Singapore-based company Us2.ai to integrate the company’s AI-based image analysis software into the clinical workflows of the LISENDO 880 and... Read More →
Diagnosing diseases and saving lives with AI featuring IMVARIA
Dr. Joshua Reicher, co-founder and CEO of IMVARIA, initially missed the opportunity to develop a company similar to DraftKings and instead decided to focus on saving lives. As a serial entrepreneur, he has been committed to using artificial intelligence to... Read More →
AtaCor Medical Enrolls First Patients in its ASCEND EV Clinical Study
SAN CLEMENTE, Calif., March 24, 2025 /PRNewswire/ — AtaCor Medical, Inc., a privately-held medical device company focused on transforming cardiac rhythm management, announced today that it has initiated its ASCEND EV study. The prospective, non-randomized international study aims to evaluate... Read More →
Kevin Kearney Joins Lungpacer Medical as Chief Commercial Officer
Company Appoints Medical Device and Healthcare Industry Veteran with 20 Years of Experience EXTON, Pa., March 24, 2025 (GLOBE NEWSWIRE) — Lungpacer Medical today announced the appointment of Kevin Kearney as Chief Commercial Officer (CCO). Kearney brings over 20 years... Read More →
Accuryn Medical Announces Leadership Transition With Appointment of Todd Dunn as CEO
HAYWARD, Calif., March 21, 2025 /PRNewswire/ — Accuryn Medical, a company dedicated to addressing acute kidney injury through real-time renal monitoring and assessment based on global clinical practice guidelines, today announced that Todd Dunn, Accuryn’s Chief Transformation Officer, will transition... Read More →